Repligen Corp vs. Twist Bioscience Corporation Common Stock
Repligen Corp (RGEN) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| RGEN | TWST | |
|---|---|---|
| Market Cap | $9.48 billion | $10.31 billion |
| Revenue (TTM) | $785.10 million | $431.80 million |
| Net Income (TTM) | $41.54 million | $-136,717,000 |
RGEN leads on 2 of 3 size & scale factors.
Valuation
| RGEN | TWST | |
|---|---|---|
| P/E Ratio | 239.36 | — |
| Price / Book | 4.49 | 23.14 |
| Price / Sales | 12.08 | 23.89 |
RGEN leads on 2 of 2 valuation factors.
Profitability
| RGEN | TWST | |
|---|---|---|
| Net Margin | 5.29% | -31.66% |
| Return on Equity | 1.97% | -30.67% |
RGEN leads on 2 of 2 profitability factors.
Risk & Sentiment
| RGEN | TWST | |
|---|---|---|
| Short Interest | 7.13% | 0.08% |
TWST leads on 1 of 1 risk & sentiment factors.
Dig deeper: RGEN overview, RGEN financials, TWST overview, TWST financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.